Volume 17, Issue 4 pp. 177-182
Research Article

Extracorporeal photopheresis reduces the number of mononuclear cells that produce pro-inflammatory cytokines, when tested ex-vivo

John Bladon

Corresponding Author

John Bladon

Department of Haematology, Rotherham General Hospital, South Yorkshire, United Kingdom

Department of Haematology, Rotherham General Hospital, South Yorkshire, S60 2UD, UKSearch for more papers by this author
Peter Taylor

Peter Taylor

Department of Haematology, Rotherham General Hospital, South Yorkshire, United Kingdom

Search for more papers by this author
First published: 19 December 2002
Citations: 19

Abstract

Extracorporeal photopheresis (ECP) has been shown to be clinically effective in the treatment of many T cell–mediated conditions. ECP's mechanism of action includes the induction of apoptosis and the release of pro-inflammatory cytokines. Recently, we have observed early lymphoid apoptosis, detectable immediately post ECP. We were interested to determine what influence ECP has on pro-inflammatory cytokine secretion at this early pre-infusion stage. Samples from 6 cutaneous T cell lymphoma (CTCL) and 5 graft versus host disease (GvHD) patients were taken pre ECP and immediately post ECP, prior to re-infusion. Following separation, the PBMCs were added to a cell culture medium and stimulated with PMA, Ionomycin, and Brefeldin A for 6 hours. Using flow cytometry, intracellular cytokine expression of IFNγ and TNFα was determined in the T cell population. The monocytes were evaluated for IL6, IFNγ, IL12, and TNFα. For both patient groups, the number of IFNγ-expressing T cells fell significantly at re-infusion, whilst both T cell- and monocyte-expressing TNFα levels were reduced at re-infusion. All other cytokines tested showed no significant change post ECP. For GvHD, pro-inflammatory cytokines have a pathological role. Their down-regulation may have a direct clinical benefit. However, the reduction in the number of IFNγ- and TNFα-expressing mononuclear cells means, at this early stage, it is unlikely that these cytokines assist in the removal of the malignant Th2 cells present in CTCL. J. Clin. Apheresis 17:177–182, 2002. © 2002 Wiley-Liss, Inc.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.